Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

More Atrophy of Deep Gray Matter Structures in Frontotemporal Dementia Compared to Alzheimer's Disease.

Möller C, Dieleman N, van der Flier WM, Versteeg A, Pijnenburg Y, Scheltens P, Barkhof F, Vrenken H.

J Alzheimers Dis. 2014 Oct 16. [Epub ahead of print]

PMID:
25322925
[PubMed - as supplied by publisher]
2.

Trajectories of cognitive decline in different types of dementia.

Smits LL, van Harten AC, Pijnenburg YA, Koedam EL, Bouwman FH, Sistermans N, Reuling IE, Prins ND, Lemstra AW, Scheltens P, van der Flier WM.

Psychol Med. 2014 Sep 17:1-9. [Epub ahead of print]

PMID:
25229325
[PubMed - as supplied by publisher]
3.

The Heart-Brain Connection: A Multidisciplinary Approach Targeting a Missing Link in the Pathophysiology of Vascular Cognitive Impairment.

van Buchem MA, Biessels GJ, Brunner la Rocca HP, de Craen AJ, van der Flier WM, Ikram MA, Kappelle LJ, Koudstaal PJ, Mooijaart SP, Niessen W, van Oostenbrugge R, de Roos A, van Rossum AC, Daemen MJ.

J Alzheimers Dis. 2014 Sep 11. [Epub ahead of print]

PMID:
25213769
[PubMed - as supplied by publisher]
4.

Angiotensin-Converting Enzyme in Cerebrospinal Fluid and Risk of Brain Atrophy.

Jochemsen HM, van der Flier WM, Ashby EL, Teunissen CE, Jones RE, Wattjes MP, Scheltens P, Geerlings MI, Kehoe PG, Muller M.

J Alzheimers Dis. 2014 Sep 8. [Epub ahead of print]

PMID:
25201786
[PubMed - as supplied by publisher]
5.

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic.

Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Aug 21. pii: S1552-5260(14)02461-3. doi: 10.1016/j.jalz.2014.05.1753. [Epub ahead of print]

PMID:
25156643
[PubMed - as supplied by publisher]
6.

7T T2-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease.

van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, van der Flier WM, Scheltens P, Barkhof F, Weverling-Rynsburger AW, Blauw GJ, Reiber JH, van Buchem MA, Milles J, van der Grond J.

Neurobiol Aging. 2014 Jul 15. pii: S0197-4580(14)00475-8. doi: 10.1016/j.neurobiolaging.2014.07.006. [Epub ahead of print]

PMID:
25113794
[PubMed - as supplied by publisher]
7.

Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort.

Cohn-Hokke PE, Wong TH, Rizzu P, Breedveld G, van der Flier WM, Scheltens P, Baas F, Heutink P, Meijers-Heijboer EJ, van Swieten JC, Pijnenburg YA.

J Neurol. 2014 Aug 10. [Epub ahead of print]

PMID:
25108559
[PubMed - as supplied by publisher]
8.

Widespread disruption of functional brain organization in early-onset Alzheimer's disease.

Adriaanse SM, Binnewijzend MA, Ossenkoppele R, Tijms BM, van der Flier WM, Koene T, Smits LL, Wink AM, Scheltens P, van Berckel BN, Barkhof F.

PLoS One. 2014 Jul 31;9(7):e102995. doi: 10.1371/journal.pone.0102995. eCollection 2014.

PMID:
25080229
[PubMed - in process]
Free PMC Article
9.

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.

Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A; International Genomics of Alzheimer's Project (IGAP); Alzheimer's Disease Neuroimaging Initiative (ADNI), Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM.

Hum Mol Genet. 2014 Jul 15. pii: ddu372. [Epub ahead of print]

PMID:
25027320
[PubMed - as supplied by publisher]
10.

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer¿s disease correlates with pathology.

Rosenberger A, Rozemuller A, van der Flier WM, Scheltens P, van der Vies SM, Hoozemans J.

Acta Neuropathol Commun. 2014 Jul 16;2(1):79. [Epub ahead of print]

PMID:
25027113
[PubMed - as supplied by publisher]
Free PMC Article
11.

Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.

Benedictus MR, Binnewijzend MA, Kuijer JP, Steenwijk MD, Versteeg A, Vrenken H, Scheltens P, Barkhof F, van der Flier WM, Prins ND.

Neurobiol Aging. 2014 Jun 13. pii: S0197-4580(14)00402-3. doi: 10.1016/j.neurobiolaging.2014.06.001. [Epub ahead of print]

PMID:
25018106
[PubMed - as supplied by publisher]
12.

Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies.

Binnewijzend MA, Kuijer JP, van der Flier WM, Benedictus MR, Möller CM, Pijnenburg YA, Lemstra AW, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F.

Eur Radiol. 2014 Sep;24(9):2326-33. doi: 10.1007/s00330-014-3172-3. Epub 2014 Jul 5.

PMID:
24996793
[PubMed - in process]
13.

The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease.

Jochemsen HM, Teunissen CE, Ashby EL, van der Flier WM, Jones RE, Geerlings MI, Scheltens P, Kehoe PG, Muller M.

Alzheimers Res Ther. 2014 May 15;6(3):27. doi: 10.1186/alzrt257. eCollection 2014.

PMID:
24987467
[PubMed]
Free PMC Article
14.

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J.

Hum Mol Genet. 2014 Jun 27. pii: ddu334. [Epub ahead of print]

PMID:
24973356
[PubMed - as supplied by publisher]
Free Article
15.

Disturbed phase relations in white matter hyperintensity based vascular dementia: An EEG directed connectivity study.

van Straaten EC, den Haan J, de Waal H, van der Flier WM, Barkhof F, Prins ND, Stam CJ.

Clin Neurophysiol. 2014 Jun 4. pii: S1388-2457(14)00293-4. doi: 10.1016/j.clinph.2014.05.018. [Epub ahead of print]

PMID:
24969377
[PubMed - as supplied by publisher]
16.

The Influence of Co-Morbidity and Frailty on the Clinical Manifestation of Patients with Alzheimer's Disease.

Oosterveld SM, Kessels RP, Hamel R, Ramakers IH, Aalten P, Verhey FR, Sistermans N, Smits LL, Pijnenburg YA, van der Flier WM, Olde Rikkert MG, Melis RJ.

J Alzheimers Dis. 2014 Jun 2. [Epub ahead of print]

PMID:
24898646
[PubMed - as supplied by publisher]
17.

Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images.

Zwan MD, Ossenkoppele R, Tolboom N, Beunders AJ, Kloet RW, Adriaanse SM, Boellaard R, Windhorst AD, Raijmakers P, Adams H, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

J Nucl Med. 2014 Jun 4;55(8):1305-1307. [Epub ahead of print]

PMID:
24898026
[PubMed - as supplied by publisher]
18.

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.

Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM.

JAMA Neurol. 2014 Jul 1;71(7):855-62. doi: 10.1001/jamaneurol.2014.754.

PMID:
24818585
[PubMed - indexed for MEDLINE]
19.

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M; Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement. 2014 May 3. pii: S1552-5260(14)00002-8. doi: 10.1016/j.jalz.2014.01.001. [Epub ahead of print]

PMID:
24798886
[PubMed - as supplied by publisher]
20.

Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.

Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN.

Neurology. 2014 May 20;82(20):1768-75. doi: 10.1212/WNL.0000000000000432. Epub 2014 Apr 18.

PMID:
24748672
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk